HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $21 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Robert Burns reiterates Nuvation Bio (NYSE:NUVB) with a Buy and maintains $21 price target.